1. Pharmacokinetic Changes During Extracorporeal Membrane Oxygenation

   • Marcia L. Buck

   Leading Article 30 September 2012 Pages: 403 - 417

   

2. Pharmacokinetics of Pegylated Liposomal Doxorubicin

   • Alberto Gabizon
   • Hilary Shmeeda
   • Yechezkel Barenholz

   Review Article 30 September 2012 Pages: 419 - 436

   

3. Clinical Pharmacokinetics of Antioxidants and Their Impact on Systemic Oxidative Stress

   • Edzard Schwedhelm
   • Renke Maas
   • Rainer H. Böger

   Review Article 30 September 2012 Pages: 437 - 459

   

4. Transdermal Drug Delivery of Insulin with Ultradeformable Carriers

   • Gregor Cevc

   Review Article 30 September 2012 Pages: 461 - 474

   

5. No Influence of Ethnic Origin on the Pharmacokinetics and Pharmacodynamics of Melagatran Following Oral Administration of Ximelagatran, a Novel Oral Direct Thrombin Inhibitor, to Healthy Male Volunteers

   • Linda C. Johansson
   • Magnus Andersson
   • Ulf G. Eriksson

   Original Research Article 30 September 2012 Pages: 475 - 484

   

6. No Influence of Obesity on the Pharmacokinetics and Pharmacodynamics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran

   • Troy C. Sarich
   • Renli Teng
   • Ulf G. Eriksson

   Original Research Article 30 September 2012 Pages: 485 - 492

   

7. Aminoglycoside Dosages and Nephrotoxicity

   • Florent Rougier
   • Michel Ducher
   • Pascal Maire

   Original Research Article 30 September 2012 Pages: 493 - 500